BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27552962)

  • 21. Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome.
    Kim YH; Bishop K; Varghese A; Hoppe RT
    Arch Dermatol; 1995 Sep; 131(9):1003-8. PubMed ID: 7661601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma.
    Gerami P; Rosen S; Kuzel T; Boone SL; Guitart J
    Arch Dermatol; 2008 Jun; 144(6):738-46. PubMed ID: 18559762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Factors and Survival Outcomes Among Patients With Mycosis Fungoides in China: A 12-Year Review.
    Chen Z; Lin Y; Qin Y; Qu H; Zhang Q; Li Y; Wen Y; Sun J; Tu P; Gao P; Wang Y
    JAMA Dermatol; 2023 Oct; 159(10):1059-1067. PubMed ID: 37585188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case-control study of clinicopathologic features, prognosis, and therapeutic responses in patients with granulomatous mycosis fungoides.
    Li JY; Pulitzer MP; Myskowski PL; Dusza SW; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2013 Sep; 69(3):366-74. PubMed ID: 23685027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of mortality, prognostic parameters, and treatment efficacy in mycosis fungoides.
    Porkert S; Griss J; Hudelist-Venz M; Steiner I; Valencak J; Weninger W; Brunner PM; Jonak C
    J Dtsch Dermatol Ges; 2024 Apr; 22(4):532-550. PubMed ID: 38444271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious Lymphomas.
    Vergier B; de Muret A; Beylot-Barry M; Vaillant L; Ekouevi D; Chene G; Carlotti A; Franck N; Dechelotte P; Souteyrand P; Courville P; Joly P; Delaunay M; Bagot M; Grange F; Fraitag S; Bosq J; Petrella T; Durlach A; De Mascarel A; Merlio JP; Wechsler J
    Blood; 2000 Apr; 95(7):2212-8. PubMed ID: 10733487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis.
    Kim YH; Jensen RA; Watanabe GL; Varghese A; Hoppe RT
    Arch Dermatol; 1996 Nov; 132(11):1309-13. PubMed ID: 8915308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of a Proposed New Staging System for Folliculotropic Mycosis Fungoides With Prognostic Variables in a US Cohort.
    Charli-Joseph Y; Kashani-Sabet M; McCalmont TH; Kornak J; Allen I; Ai WZ; LeBoit PE; Pincus LB
    JAMA Dermatol; 2021 Feb; 157(2):157-165. PubMed ID: 33295938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total body-surface area as a new prognostic variable in mycosis fungoides and Sézary syndrome.
    Novelli S; García-Muret P; Mozos A; Sierra J; Briones J
    Leuk Lymphoma; 2016 May; 57(5):1060-6. PubMed ID: 27096891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients.
    Scarisbrick JJ; Quaglino P; Prince HM; Papadavid E; Hodak E; Bagot M; Servitje O; Berti E; Ortiz-Romero P; Stadler R; Patsatsi A; Knobler R; Guenova E; Child F; Whittaker S; Nikolaou V; Tomasini C; Amitay I; Prag Naveh H; Ram-Wolff C; Battistella M; Alberti-Violetti S; Stranzenbach R; Gargallo V; Muniesa C; Koletsa T; Jonak C; Porkert S; Mitteldorf C; Estrach T; Combalia A; Marschalko M; Csomor J; Szepesi A; Cozzio A; Dummer R; Pimpinelli N; Grandi V; Beylot-Barry M; Pham-Ledard A; Wobser M; Geissinger E; Wehkamp U; Weichenthal M; Cowan R; Parry E; Harris J; Wachsmuth R; Turner D; Bates A; Healy E; Trautinger F; Latzka J; Yoo J; Vydianath B; Amel-Kashipaz R; Marinos L; Oikonomidi A; Stratigos A; Vignon-Pennamen MD; Battistella M; Climent F; Gonzalez-Barca E; Georgiou E; Senetta R; Zinzani P; Vakeva L; Ranki A; Busschots AM; Hauben E; Bervoets A; Woei-A-Jin FJSH; Matin R; Collins G; Weatherhead S; Frew J; Bayne M; Dunnill G; McKay P; Arumainathan A; Azurdia R; Benstead K; Twigger R; Rieger K; Brown R; Sanches JA; Miyashiro D; Akilov O; McCann S; Sahi H; Damasco FM; Querfeld C; Folkes A; Bur C; Klemke CD; Enz P; Pujol R; Quint K; Geskin L; Hong E; Evison F; Vermeer M; Cerroni L; Kempf W; Kim Y; Willemze R
    Br J Dermatol; 2019 Aug; 181(2):350-357. PubMed ID: 30267549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transformed mycosis fungoides: clinicopathological features and outcome.
    Barberio E; Thomas L; Skowron F; Balme B; Dalle S
    Br J Dermatol; 2007 Aug; 157(2):284-9. PubMed ID: 17573879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total skin electron beam therapy in mycosis fungoides. Our experience from 1985 to 1999.
    Rampino M; Ragona R; Monetti U; Mussano A; Guarneri A; Sannazzari GL
    Radiol Med; 2002; 103(1-2):108-14. PubMed ID: 11859306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitation of tumour development correlates with prognosis in tumour stage (stage IIB) mycosis fungoides.
    Boonk SE; Putter H; Koolhof L; Willemze R; Vermeer MH
    Br J Dermatol; 2014 May; 170(5):1080-6. PubMed ID: 24299563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factor analysis in mycosis fungoides/Sézary syndrome.
    Diamandidou E; Colome M; Fayad L; Duvic M; Kurzrock R
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):914-24. PubMed ID: 10365922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor stage mycosis fungoides: a single-center study on clinicopathologic features, treatments, and patient outcome.
    Patrawala SA; Broussard KC; Wang L; Zic JA
    Dermatol Online J; 2016 May; 22(5):. PubMed ID: 27617516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognosis of primary cutaneous lymphomas].
    Grange F; Bagot M
    Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):30-40. PubMed ID: 11937927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of phototherapy on progression to tumors in patients with patch and plaque stage of mycosis fungoides.
    Hoot JW; Wang L; Kho T; Akilov OE
    J Dermatolog Treat; 2018 May; 29(3):272-276. PubMed ID: 28782389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycosis fungoides with large cell transformation: clinicopathological features and prognostic factors.
    Pulitzer M; Myskowski PL; Horwitz SM; Querfeld C; Connolly B; Li J; Murali R
    Pathology; 2014 Dec; 46(7):610-6. PubMed ID: 25393251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognosis of 100 Japanese patients with mycosis fungoides and Sézary syndrome.
    Suzuki SY; Ito K; Ito M; Kawai K
    J Dermatol Sci; 2010 Jan; 57(1):37-43. PubMed ID: 19931424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.